NYSE : NMR
$0.04 (0.41%)
NYSE
Kentaro Okuda
Financial - Capital Markets
Financial Services
NMR
28677
JP
USD
9.91
0.77
0.77
0.23
0.00
$4.76T
0.03
1.26
0.00
0.00
$118.99
$362.13B
8.25%
12.25%
404.11%
23.09%
0.33
0.00
0.00
$10.20
$10.20
$10.20
2/5
9 Analysts
-3.82%
0.54
6/9
$17.65T
$62.65T
$58.79T
$539.82B
$37.12T
0.21
1.72
0.77
404.11%
24.02%
311.67%
0.00%
$11974.57
4 days
| Name | Title |
|---|---|
| Satoshi Kawamura | Senior Managing Director |
| Masato Kohno | Senior Managing Director of Executive Management Headquarters & Executive Management and Resilience |
| Kentaro Okuda | President, Group Chief Executive Officer, Representative Executive Officer & Director |
| Nicolas Bertrand | Chief Executive Officer of Komainu |
| Sotaro Kato | Executive Officer & Chief Risk Officer |
| Takumi Kitamura | Executive Officer & Chief Transformation Officer |
| Toshiyasu Iiyama | Chief of Staff, Executive Officer, Head of Well Growing Institute & Deputy President |
| Yutaka Nakajima | Representative Executive Officer, Deputy President & Director |
| Jim Voorheis | MD for Financial Institutions Group |
| Eric O'Dell | Managing Director of Automotive Industry |
| Patrick Eltridge | Senior MD & Chief Information Officer |
| Thomas Chung | MD and Head of Private Capital Markets for Equity Capital Markets Group |
| Gareth Nicholson | Executive Director, Chief Investment Officer & Head of Discretionary Portfolio Management |
| Yosuke Inaida | Senior MD & Head of Content Company and Global Regulatory Affairs |
| Akihiro Koseki | MD, Head of Investor Relations & Co-Head of Investment Banking - Asia ex-Japan |
| Robert Subbaraman | Head of Emerging Markets Economics |
| Samuel Evans | MD & Head of Private Capital Markets of the Equity Capital Markets Group |
| Shinichi Mizuno | Senior MD, Joint Chief Compliance Officer & Audit Mission Director. |
| Takako Mori | Senior MD of General Counsel & Joint Chief Compliance Officer |
| Christopher Paul Willcox | Executive Officer, Deputy President, Head of Wholesale & Chairman of Investment Management |
| Douglas S. Yablonski | Managing Director of the M&A Group |
| Hiroyuki Moriuchi | Executive Officer & Chief Financial Officer |
| Nihal Elkafrawi | MD & Head of Client Coverage for the Middle East and North Africa |
| Nicholas Ellmore | Managing Director |
No votes yet today — be the first to share your view!
About Nomura Holdings, Inc. (NYSE:NMR) Stock
Nomura Holdings, Inc. engages in the provision of investment, financing, and related services to individual, institutional, and government clients worldwide. It operates through three segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management segment offers investment consultation services. The Investment Management segment provides investment management services and investment solutions, such as establishing and managing investment trusts, discretionary investment services, as well as investment and management for investment vehicles, and for funds for institutional investors, and management of silent partnerships. The Wholesale segment is involved in the sales and trading of debt and equity securities, foreign exchange contracts and derivatives; offers inves ... tment banking services, including underwriting and distribution of debt and equity securities, mergers and acquisitions, and financial advisory. The company was formerly known as The Nomura Securities Co., Ltd. and changed its name to Nomura Holdings, Inc. in October 2001. Nomura Holdings, Inc. was incorporated in 1925 and is headquartered in Tokyo, Japan.
Nomura Core Equity Fund Q2 2026 Portfolio Review
2026-07-22 12:35:00
Seagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions. On balance, the Fund's artificial intelligence positioning was a net positive contributor to relative performance during the quarter. We added the Humana position on the view that earnings are at a cyclical trough, with MA margins currently depressed, in some cases negative, as elevated medical cost trends have outpaced premium growth across the industry.
Is Nomura (NMR) Stock Undervalued Right Now?
2026-07-22 10:41:20
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NMR vs. MKTX: Which Stock Is the Better Value Option?
2026-07-15 12:41:03
Investors looking for stocks in the Financial - Investment Bank sector might want to consider either Nomura Holdings (NMR) or MarketAxess (MKTX). But which of these two stocks is more attractive to value investors?
Nomura: Favorable Prospects For Core Segments
2026-07-09 09:13:04
I stick to a 'Buy' rating for Nomura Holdings, Inc., after assessing the outlook for its major Wholesale and Wealth Management divisions. The Wholesale business has ROE expansion potential, considering internal portfolio restructuring initiatives and favorable external M&A trends. The Wealth Management unit is broadening its product portfolio and penetrating high-potential client segments to raise the future proportion of recurring revenues.
Should Value Investors Buy Nomura (NMR) Stock?
2026-07-06 10:40:31
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NMR or MKTX: Which Is the Better Value Stock Right Now?
2026-06-29 12:40:14
Investors interested in stocks from the Financial - Investment Bank sector have probably already heard of Nomura Holdings (NMR) and MarketAxess (MKTX). But which of these two stocks offers value investors a better bang for their buck right now?
Nomura Raises CEO Pay 36% After Posting Record Annual Profit
2026-06-23 14:04:00
Nomura Holdings (NMR) has lifted CEO Kentaro Okuda's compensation by 36% to ¥1.6 billion, or about $10 million, for the year ended March 31, after the Japanese
Are Investors Undervaluing Nomura (NMR) Right Now?
2026-06-17 10:40:33
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Frequently Asked Questions
What is the current Nomura Holdings, Inc. (NMR) stock price?
Nomura Holdings, Inc.(NYSE:NMR) stock price is $9.81 in the last trading session. During the trading session, NMR stock reached the peak price of $10.06 while $6.59 was the lowest point it dropped to. The percentage change in NMR stock occurred in the recent session was 0.41% while the dollar amount for the price change in NMR stock was $0.04.
NMR's industry and sector of operation?
The NYSE listed NMR is part of Financial - Capital Markets industry that operates in the broader Financial Services sector.
Who are the executives of NMR?
Satoshi Kawamura
| Senior Managing Director
Masato Kohno
| Senior Managing Director of Executive Management Headquarters & Executive Management and Resilience
Kentaro Okuda
| President, Group Chief Executive Officer, Representative Executive Officer & Director
Nicolas Bertrand
| Chief Executive Officer of Komainu
Sotaro Kato
| Executive Officer & Chief Risk Officer
How many employees does NMR have?
Number of NMR employees currently stands at 28677. NMR operates from 13-1, Nihonbashi 1-chome, Tokyo, TY 103-8645, JP.
Link for NMR official website?
Official Website of NMR is: https://www.nomura.com
How do I contact NMR?
NMR could be contacted at phone #81 3 5255 1000 and can also be accessed through its website. NMR operates from 13-1, Nihonbashi 1-chome, Tokyo, TY 103-8645, JP.
How many shares of NMR are traded daily?
The average number of NMR shares traded daily for last 3 months was 1.32M.
What is the market cap of NMR currently?
The market value of NMR currently stands at $28.67B with its latest stock price at $9.81